Specific detection of human coagulation factor IX in cynomolgus macaques

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 2, 2004, Pages 275-280

  Mimuro, J ^a   Mizukami, H ^a   Ono, F ^b   Madoiwa, S ^a   Terao, K ^b   Yoshioka, A ^c   Ozawa, K ^a   Sakata, Yoichi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cynomolgus macaque; Factor IX; Hemophilia B

Indexed keywords

ALANINE; BLOOD CLOTTING FACTOR 9; BUFFER; EPITOPE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3A6; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIBODY DETECTION; ANTIGEN BINDING; ARTICLE; BLOOD CLOTTING TEST; CONTROLLED STUDY; DOG; ENZYME IMMUNOASSAY; GENE EXPRESSION; GENE THERAPY; GENE VECTOR; GENETIC TRANSDUCTION; HEMOPHILIA B; HYDROLYSIS; MACACA; NONHUMAN; PLASMA; PRIORITY JOURNAL; SPECIES DIFFERENCE; ANIMAL; CHEMISTRY; DISEASE MODEL; HUMAN; INJECTION; LIVER; TISSUE DISTRIBUTION;

ANIMALS; ANTIBODIES, MONOCLONAL; DISEASE MODELS, ANIMAL; EPITOPES; FACTOR IX; HEMOPHILIA B; HUMANS; IMMUNOENZYME TECHNIQUES; INJECTIONS; LIVER; MACACA FASCICULARIS; TISSUE DISTRIBUTION;

EID: 4644357580     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1538-7933.2003.00572.x     Document Type: Article

References (18)

1. Kay MA, High K. Gene therapy for the hemophilias. Proc Natl Acad Sci USA 1999; 96: 9973-5.
2. High KA. Gene transfer as an approach to treating hemophilia. Circ Res 2001; 88: 137-44.
3. Kay MA, Rothenberg S, Landen CN, Bellinger DA, Leland F, Toman C, Finegold M, Thompson AR, Read MS, Brinkhous KM. In vivo gene therapy of hemophilia B: sustained partial correction in factor IX-deficient dogs. Science 1993; 262: 117-9.
4. Snyder RO, Miao CH, Patijn GA, Spratt SK, Danos O, Nagy D, Gown AM, Winther B, Meuse L, Cohen LK, Thompson AR, Kay MA. Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors. Nat Genet 1997; 16: 270-6.
5. Herzog RW, Yang EY, Couto LB, Hagstrom JN, Elwell D, Fields PA, Burton M, Bellinger DA, Read MS, Brinkhous KM, Podsakoff GM, Nichols TC, Kurtzman GJ, High KA. Long-term correction of canine hemophilia B by gene transfer of blood coagulation factor IX mediated by adeno-associated viral vector. Nat Med 1999; 5: 56-63.
6. Snyder RO, Miao C, Meuse L, Tubb J, Donahue BA, Lin HF, Stafford DW, Patel S, Thompson AR, Nichols T, Read MS, Bellinger DA, Brinkhous KM, Kay MA. Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors. Nat Med 1999; 5: 64-70.
7. Kay MA, Manno CS, Ragni MV, Larson PJ, Couto LB, McClelland A, Glader B, Chew AJ, Tai SJ, Herzog RW, Arruda V, Johnson F, Scallan C, Skarsgard E, Flake AW, High KA. Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet 2000; 24: 257-61.
8. Manno CS, Chew AJ, Hutchison S, Larson PJ, Herzog RW, Arruda VR, Jen Tai S, Ragni MV, Thompson A, Ozelo M, Couto LB, Leonard DGB, Johnson FA, McClelland A, Scallan C, Skarsgard E, Flake AW, Kay MA, High HA, Glader B. AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B. Blood 2003; 101: 2963-72.
9. Yoshioka A, Giddings JC, Fujimura TY, Bloom AL. Immunoassays of factor IX antigen using monoclonal antibodies. Br J Hematol 1985; 59: 265-75.
10. Sugo T, Mizuguchi J, Kamikubo Y, Matsuda M. Anti-human factor IX monoclonal antibodies specific for calcium ion-induced conformations. Thromb Res 1990; 58: 603-14.
11. Mimuro J, Sakata Y, Wakabayashi K, Matsuda M. Level of protein C determined by combined assays during disseminated intravascular coagulation and oral anticoagulation. Blood 1987; 69: 1704-11.
12. Sugo T, Nakamikawa C, Takano H, Mimuro J, Yamaguchi S, Mosesson MW, Meh DA, DiOrio JP, Takahashi N, Takahashi H, Nagai K, Matsuda M. Fibrinogen Niigata with impaired fibrin assembly: an inherited dysfibrinogen with a Bβ Asn-160 to Ser substitution associated with extra glycosylation at Bβ Asn-158. Blood 1999; 94: 3806-13.
13. Lozier JN, Metzger ME, Donahue RE, Morgan RA. The rhesus macaque as an animal model for hemophilia B gene therapy. Blood 1999; 93: 1875-81.
14. Tomokiyo K, Teshima K, Nakatomi Y, Wtanabe T, Mizuguchi J, Nozaki C, Nakagaki T, Miyamoto S, Funatsu A, Iwanaga S. Induction of acquired factor LX inhibitors in cynomolgus monkey (Macaca fascicularis): a new primate model of hemophilia B. Thromb Res 2001; 102: 363-74.
15. Zaubei PN, Levin J. Factor IX levels in patients with hemophilia B (Christmas disease) following transfusion with concentrates of factor IX or fresh frozen plasma. Medicine 1977; 56: 213-24.
16. MacCarthy K, Stewart P, Sigman J, Read M, Keith JC Jr, Brinkhous KM, Nichols TC, Schaub RG. Pharmacokinetics of recombinant factor IX after inravenous and subcutaneous administration in dogs and cynomolgus monkey. Thromb Haemost 2002; 87: 824-30.
17. Nathwani AC, Davidoff AD, Hanawa H, Hu Y, Hoffer FA, Nikanorov A, Slaughter C, Ng C, Zhou J, Lozier JN, Mandrell TD, Vanin EF, Nienhuis W. Sustained high-level expression of human factor IX (hFIX) after liver-targeted delivery of recombinant adeno-associated virus encoding the hFIX gene in rhesus macaques. Blood 2002; 100: 1662-9.
18. Chao H, Liu Y, Rabinowitz J, Li C, Samulski RJ, Walsh CE. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2000; 2: 619-23.